pharmaceutical services insurance

Summary

Summary: Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.

Top Publications

  1. ncbi Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada
    Fiona M Clement
    Department of Medicine, University of Calgary, Calgary, Alberta, Canada
    JAMA 302:1437-43. 2009
  2. ncbi Impact of medication adherence on hospitalization risk and healthcare cost
    Michael C Sokol
    Department of Medical Affairs, Medco Health Solutions, Inc, Franklin Lakes, New Jersey 07417, USA
    Med Care 43:521-30. 2005
  3. ncbi Whither seniors' pharmacare: lessons from (and for) Canada
    Steven G Morgan
    Centre for Health Services and Policy Research, University of British Columbia
    Health Aff (Millwood) 22:49-59. 2003
  4. ncbi Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter?
    A S Adams
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts, USA
    Health Aff (Millwood) 20:276-86. 2001
  5. ncbi Over-the-counter drug use by medicare beneficiaries in nursing homes: implications for practice and policy
    Linda Simoni-Wastila
    Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    J Am Geriatr Soc 54:1543-9. 2006
  6. doi Tier 4 drugs and the fraying of the social compact
    Thomas H Lee
    Partners HealthCare System, Boston, USA
    N Engl J Med 359:333-5. 2008
  7. pmc Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001
    Jeffrey A Johnson
    Institute of Health Economics, Edmonton, Canada
    BMC Health Serv Res 6:159. 2006
  8. ncbi Promise and perils for patients and physicians
    Richard L Kravitz
    Center for Health Services Research in Primary Care, University of California, Davis, Calif, USA
    N Engl J Med 353:2735-9. 2005
  9. ncbi Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada
    Gillian E Hanley
    Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC, Canada
    Health Econ 17:1379-92. 2008
  10. pmc Medigap reform legislation of 1990: a 10-year review
    Peter D Fox
    Health Care Financ Rev 24:121-37. 2003

Detail Information

Publications225 found, 100 shown here

  1. ncbi Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada
    Fiona M Clement
    Department of Medicine, University of Calgary, Calgary, Alberta, Canada
    JAMA 302:1437-43. 2009
    ..This study describes how that evidence has been used across 3 jurisdictions (Australia, Canada, and Britain) that have been at the forefront of evidence-based coverage internationally...
  2. ncbi Impact of medication adherence on hospitalization risk and healthcare cost
    Michael C Sokol
    Department of Medical Affairs, Medco Health Solutions, Inc, Franklin Lakes, New Jersey 07417, USA
    Med Care 43:521-30. 2005
    ....
  3. ncbi Whither seniors' pharmacare: lessons from (and for) Canada
    Steven G Morgan
    Centre for Health Services and Policy Research, University of British Columbia
    Health Aff (Millwood) 22:49-59. 2003
    ..Sustainable and equitable pharmacare programs require the political willingness to confront opposition to policies that will, if successful, contain program costs without obstructing access...
  4. ncbi Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter?
    A S Adams
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts, USA
    Health Aff (Millwood) 20:276-86. 2001
    ....
  5. ncbi Over-the-counter drug use by medicare beneficiaries in nursing homes: implications for practice and policy
    Linda Simoni-Wastila
    Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    J Am Geriatr Soc 54:1543-9. 2006
    ..To examine over-the-counter (OTC) medication use by Medicare beneficiaries in nursing homes and to assess evidence of substitution of OTC medications for prescription (Rx) medications by residents with no Rx coverage and Medicaid...
  6. doi Tier 4 drugs and the fraying of the social compact
    Thomas H Lee
    Partners HealthCare System, Boston, USA
    N Engl J Med 359:333-5. 2008
  7. pmc Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001
    Jeffrey A Johnson
    Institute of Health Economics, Edmonton, Canada
    BMC Health Serv Res 6:159. 2006
    ..Those individuals with type 2 diabetes who used insulin had higher testing supply costs than those on oral antidiabetic medication alone (359 vs 131 dollars; p < 0.001)...
  8. ncbi Promise and perils for patients and physicians
    Richard L Kravitz
    Center for Health Services Research in Primary Care, University of California, Davis, Calif, USA
    N Engl J Med 353:2735-9. 2005
  9. ncbi Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada
    Gillian E Hanley
    Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC, Canada
    Health Econ 17:1379-92. 2008
    ..These results suggest that income-based pharmacare can improve financial equity especially when implemented with a commitment to maintain or increase public funding for prescription drugs...
  10. pmc Medigap reform legislation of 1990: a 10-year review
    Peter D Fox
    Health Care Financ Rev 24:121-37. 2003
    ..Access to coverage for Medicare disabled beneficiaries is problematic in most States...
  11. ncbi Payment policy and inefficient benefits in the Medicare+Choice program
    Steven D Pizer
    Boston University School of Public Health, Center for Health Quality, Department of Veterans Affairs, Bedford, MA 01730, USA
    Int J Health Care Finance Econ 3:79-93. 2003
    ..These results strongly suggest that current Medicare policy induces plans to offer benefits that are not valued by enrollees at or above their cost...
  12. ncbi Doctors' perceptions and attitudes to prescribing within the Authority Prescribing System
    Siaw Teng Liaw
    Department of General Practice, The University of Melbourne, 200 Berkeley Street, Carlton, Victoria 3053, Australia
    Med J Aust 178:203-6. 2003
    ..To examine doctors' perceptions and attitudes to prescribing within the Authority Prescribing System (APS)...
  13. pmc Self-restriction of medications due to cost in seniors without prescription coverage
    M A Steinman
    Division of Geriatrics, San Francisco VA Medical Center, University of California San Francisco 94121, USA
    J Gen Intern Med 16:793-9. 2001
    ..We sought to identify which elderly patients are at highest risk of restricting their medications because of cost, and how prescription coverage modifies this risk...
  14. ncbi Dilemmas in regulation of the market for pharmaceuticals
    Alan Maynard
    University of York, England
    Health Aff (Millwood) 22:31-41. 2003
    ..Whatever the policy chosen, evaluation is as essential as it is rare...
  15. ncbi The strategic response by pharmaceutical firms to the Medicaid most-favored-customer rules
    F Scott Morton
    Stanford University, USA
    Rand J Econ 28:269-90. 1997
    ..Hospital prices show little change. The results suggest that the MFC rule caused higher prices for some pharmaceutical customers...
  16. ncbi Prescription drugs and the elderly: issues and options
    S H Long
    RAND, Washington, DC
    Health Aff (Millwood) 13:157-74. 1994
    ....
  17. ncbi Ability to pay and the decision to medicate
    B Stuart
    Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore 21201 1563, USA
    Med Care 36:202-11. 1998
    ..The magnitude of the impact was sufficiently high that it could have major negative consequences on the health of elderly persons who are poor and lack drug coverage...
  18. pmc Prescription drug coverage and spending for Medicare beneficiaries
    J A Poisal
    Office of Strategic Planning, Health Care Financing Administration, Baltimore, MD 21244, USA
    Health Care Financ Rev 20:15-27. 1999
    ..The data indicate higher-than-average levels of coverage for minority persons, beneficiaries eligible for Medicare because of disability, and those with higher incomes...
  19. ncbi Dynamics in drug coverage of Medicare beneficiaries: finders, losers, switchers
    B Stuart
    Peter Lamy Center on Drug Therapy and Aging, and Parke-Davis, University of Maryland School of Pharmacy, USA
    Health Aff (Millwood) 20:86-99. 2001
    ..The results show that fewer than half of all beneficiaries had continuous drug coverage over this period, while nearly a third gained, lost, or had spells without coverage...
  20. pmc Reporting of drug expenditures in the MCBS
    John A Poisal
    Health Care Financ Rev 25:23-36. 2003
    ..7 percent. The data also identify demographic factors that predict a beneficiary's likelihood to either overreport or underreport his or her medications, as well as the extent to which beneficiaries misreport their drug use and spending...
  21. pmc A political history of medicare and prescription drug coverage
    Thomas R Oliver
    Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, 624 N Broadway, Room 403, Baltimore, MD 21205 1999, USA
    Milbank Q 82:283-354. 2004
    ..Based on several new circumstances in 2003, the article demonstrates why there was a historic opportunity to add a Medicare prescription drug benefit and identify challenges to implementing an effective policy...
  22. ncbi Coverage and use of prescription drugs in nursing homes: implications for the medicare modernization act
    Bruce Stuart
    The Peter Lamy Center on Drug Therapy and Aging, University of Maryland, Baltimore, MD 21201, USA
    Med Care 44:243-9. 2006
    ..Understanding the impact of the MMA requires knowledge of the process by which drugs are prescribed to residents and the effect of coverage on medication use...
  23. pmc Predictability of prescription drug expenditures for Medicare beneficiaries
    Marian V Wrobel
    University of Pennsylvania School of Medicine, USA
    Health Care Financ Rev 25:37-46. 2003
    ..Adding lagged drug expenditures more than doubled predictive power to 55 percent. These results are discussed in the context of forecasting, and risk adjustment for the proposed new Medicare drug benefit...
  24. ncbi The first months of the prescription-drug benefit--a CMS update
    Peter B Bach
    Centers for Medicare and Medicaid Services, Washington, DC, USA
    N Engl J Med 354:2312-4. 2006
  25. ncbi Comparison of drug regimen costs between the Medicare prescription discount program and other purchasing systems
    John M Hayes
    JAMA 294:427-8. 2005
  26. ncbi Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme
    Jane Robertson
    Clinical Pharmacology, University of Newcastle, Calvary Mater Hospital, Waratah, Newcastle, NSW 2298
    Aust Health Rev 33:192-9. 2009
    ..In some, the lack of transparency may have reflected the desire of manufacturers to disguise the true negotiated price, lest it weaken their negotiation position in other jurisdictions...
  27. ncbi The new Medicare prescription-drug benefit--a pure power play
    John K Iglehart
    N Engl J Med 350:826-33. 2004
  28. ncbi Dramatic improvement or death spiral--two members of congress assess the Medicare bill
    Edward M Kennedy
    N Engl J Med 350:747-51. 2004
  29. ncbi Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage
    Chien Wen Tseng
    University of Hawaii Department of Family Practice and Community Health, Honolulu, and UCLA Department of Medicine, Los Angeles, Calif
    JAMA 292:952-60. 2004
    ....
  30. ncbi A prescription for a modern Medicare program
    Peter B Bach
    Dr Bach is a senior adviser and Dr McClellan the administrator of the Centers for Medicare and Medicaid Services, Washington, D C
    N Engl J Med 353:2733-5. 2005
  31. ncbi The case for a medicare drug coverage benefit: a critical review of the empirical evidence
    A S Adams
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 126 Brookline Ave, Suite 200, Boston, Massachusetts 02215, USA
    Annu Rev Public Health 22:49-61. 2001
    ..Longitudinal evidence from elderly and disabled persons in Medicaid indicates that restricting coverage has serious adverse health outcomes for sick and low-income beneficiaries that actually lead to increased health care costs...
  32. pmc Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?
    Andreas Laupacis
    Institute for Clinical Evaluative Sciences, Toronto, ON
    CMAJ 166:44-7. 2002
  33. ncbi Increasing generic drug use in Medicare Part D: the role of government
    Herb Kohl
    United States Senator from Wisconsin, Majority Leader, U S Senate Special Committee on Aging, 2nd and C St, NE, 330 Hart Senate Office Building, United States Senate, Washington, DC 20510, USA
    J Am Geriatr Soc 55:1106-9. 2007
  34. pmc Pharmacy utilization and the Medicare Modernization Act
    Vittorio Maio
    Department of Health Policy, Jefferson Medical College, Philadelphia, PA 19107, USA
    Milbank Q 83:101-30. 2005
    ..Therefore, the economic and clinical impact of PUM measures on seniors should be studied further to help policymakers design better drug benefit plans...
  35. ncbi Strategies for acquiring affordable medications for seniors
    Kathy J Morris
    Council Bluffs Community Health Center, 300 West Broadway, Suite 6, Council Bluffs, IA, 51503, USA
    Nurs Clin North Am 40:51-62, vi. 2005
    ..Some community healthcenters offer access to prescriptions at decreased costs through fed-eral programs. This article explores the various options availableto senior citizens so that nurses may act as advocates for thesepatients...
  36. ncbi Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit
    Joyce C West
    American Psychiatric Institute for Research and Education, American Psychiatric Association, Practice Research Network, 1000 Wilson Blvd, Suite 1825, Arlington, VA 22209, USA
    Am J Psychiatry 164:789-96. 2007
    ....
  37. ncbi The Medicare prescription drug plan: assisting our older patients
    Mary Nouvertne Klein
    ORL Head Neck Nurs 22:34-5. 2004
    ..This article will provide information on obtaining and implementing the benefits and discuss current legislative issues regarding prescription drug coverage...
  38. ncbi The Medicare Part D drug benefit: lessons from the experience with drug discount cards
    Paul L Doering
    College of Pharmacy, University of Florida, Gainesville, FL 32611, USA
    Am J Geriatr Cardiol 14:308-12. 2005
    ..By carefully looking back on these hurdles, perhaps one can anticipate some of the problems that will likely be encountered when the full program is implemented and assist patients in realizing its maximum benefits...
  39. ncbi Per-patient-per-month drug costs in Medicare Part D protected classes
    Lisa Mucha
    Thomson Medstat, Cambridge, MA 02140, USA
    Pharmacoeconomics 24:79-84. 2006
    ....
  40. ncbi Overview of Medicare Part D prescription drug benefit: potential implications for patients with psychotic disorders
    Jack M Rosenberg
    International Drug Information Center, Brooklyn, NY 11201, USA
    Am J Health Syst Pharm 64:S18-23; quiz S24-5. 2007
    ..Medicare Part D prescription drug benefits are reviewed. Potential implications for patients with psychotic disorders in relation to Medicare Part D are discussed...
  41. pmc Drug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues
    Malcolm Maclure
    School of Health Information Science, University of Victoria, B C V8W 3P5, Canada
    Milbank Q 83:131-47. 2005
  42. ncbi Effect of the Medicare Prescription Drug Improvement and Modernization Act on the bottom line
    Anne T Jarrett
    Wake Forest University Medical Center, Medical Center Boulevard, Winston Salem, NC 27157, USA
    Am J Health Syst Pharm 63:S10-3. 2006
    ....
  43. ncbi Medicare Part D: primer
    Carol Coakley
    Adv Nurse Pract 14:24. 2006
  44. ncbi The Medicare Prescription Drug, Improvement, and Modernization Act of 2003
    Susan Emmer
    Emmer Consulting, Bethesda, Maryland 20817, USA
    J Am Geriatr Soc 52:1013-5. 2004
  45. ncbi Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients
    Thomas Fise
    American College of Gastroenterology
    Am J Gastroenterol 99:775-6. 2004
  46. pmc Prescription drug benefits: cost management issues for Medicare
    Peter D Fox
    Health Care Financ Rev 25:7-21. 2003
    ....
  47. ncbi Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans
    Uptal D Patel
    Duke University Medical Center, Box 3646, Division of Nephrology, Durham, NC 27710, USA
    J Am Soc Nephrol 17:2546-53. 2006
    ....
  48. pmc Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children
    Haiden A Huskamp
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
    Arch Gen Psychiatry 62:435-41. 2005
    ..Many employers and health plans have adopted 3-tier formularies in an attempt to control costs for these and other drugs...
  49. ncbi Perverse incentives in the Medicare prescription drug benefit
    David McAdams
    Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
    Inquiry 44:157-66. 2007
    ..In particular, if all plans were required to charge the same premium, there would be less diversity in quality, but also less need to regulate formulary composition, less budgetary uncertainty, and less upward pressure on drug prices...
  50. ncbi Who will be denied Medicare prescription drug subsidies because of the asset test?
    Thomas Rice
    Department of Health Services, UCLA School of Public Health, 90095 1772, USA
    Am J Manag Care 12:46-54. 2006
    ..To determine the number and characteristics of Medicare beneficiaries who will be excluded from low-income prescription drug subsidies because they do not qualify under an asset test...
  51. pmc The new medicare drug benefit: formularies and their potential effects on access to medications
    Haiden A Huskamp
    Department of Health Care Policy, Harvard Medical School, Boston, Mass, USA
    J Gen Intern Med 20:662-5. 2005
    ..Such efforts should reduce administrative burden and better allow physicians to help patients obtain needed medications...
  52. ncbi PBMs to the rescue? Pharmacy benefit managers will play a key role in the Medicare drug benefit. What does it mean for the industry, consumers and Uncle Sam?
    Tony Fong
    Mod Healthc 35:26-8, 30. 2005
  53. pmc The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation
    Carmella Evans-Molina
    Department of Medicine, Division of Endocrinology and Metabolism, University of Virginia, Charlottesville, Virginia, USA
    J Am Geriatr Soc 55:1038-43. 2007
    ..To compare prescription drug cost savings under the most commonly selected Medicare Part D prescription plan in 2006 with savings under the Medicare standard benefit and with drug costs assuming no coverage in an elderly cohort of patients...
  54. ncbi States' control of prescription drug spending: a heterogeneous approach
    Nancy E Morden
    University of Washington, in Seattle, USA
    Health Aff (Millwood) 24:1032-8. 2005
    ....
  55. ncbi Prescription drug benefits under Part D of the Medicare Modernization Act--the genie's out of the bottle
    L Sue Andersen
    Health Benefits ABCs
    Issue Brief Cent Medicare Educ 5:1-10. 2005
    ..In this brief, we discuss the new Part D benefit, including who is eligible, the basic benefit, benefits for low-income individuals and coordination with other prescription drug coverage...
  56. pmc Medicare prescription drug coverage: consumer information and preferences
    Joachim Winter
    Department of Economics, University of Munich, D 80539 Munich, Germany
    Proc Natl Acad Sci U S A 103:7929-34. 2006
    ..However, there is a significant risk that many eligible seniors, particularly low-income elderly with poor health or cognitive impairment, will make poor enrollment and plan choices...
  57. ncbi Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses
    Julie M Donohue
    Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Crabtree Hall A613, Pittsburgh, Pennsylvania 15261, USA
    Psychiatr Serv 56:645-7. 2005
  58. ncbi A first look at the new Medicare prescription drug plans
    Austin B Frakt
    Veterans Affairs Boston Healthcare System in Boston, Massachusetts, USA
    Health Aff (Millwood) 25:W252-61. 2006
    ..One national stand-alone drug plan, though, covers brand-name drugs with no gap. Variations in cost sharing and formularies provide beneficiaries with choices as well as complexity...
  59. ncbi The Medicare Prescription Drug Benefit: understanding the benefits and the gaps in this new coverage
    Fay Baier
    Centers for Medicare and Medicaid Services, Seattle, WA, USA
    Am J Nurs 106:66-72. 2006
    ..Also addressed are concerns voiced by some beneficiaries about the coverage and suggestions on how to avoid confusion when choosing and enrolling in a plan...
  60. ncbi Identifying widely covered drugs and drug coverage variation among Medicare part D formularies
    Chien Wen Tseng
    Department of Family Medicine and Community Health, John A Burns School of Medicine at University of Hawaii, Honolulu, USA
    JAMA 297:2596-602. 2007
    ..Clinicians can find it difficult to know which drugs are covered for their Medicare patients because formularies vary widely among Medicare Part D plans and many states have 50 or more such plans...
  61. pmc Angiotensin receptor blockers on the formularies of Medicare drug plans
    Walid F Gellad
    Division of General Medicine and Primary Care, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 1620 Tremont Street, Boston, MA 02120 1613, USA
    J Gen Intern Med 22:1172-5. 2007
    ..The presence of angiotensin receptor blockers (ARBs) on the formularies of Medicare Part D prescription drug plans (PDPs) is vitally important to the health of seniors who cannot tolerate angiotensin-converting enzyme (ACE) inhibitors...
  62. ncbi The Medicare Modernization Act of 2003, part D
    William Simonson
    J Am Med Dir Assoc 6:231-2. 2005
  63. ncbi What will the new medicare drug benefit mean for Minnesota physicians?
    Mark Liebow
    Mayo Clinic, College of Medicine
    Minn Med 88:38-41. 2005
    ..This article explores the historical context for the law, the effects of the interim benefit for 2004 and 2005, the provisions of the benefit, and the implications for Minnesota seniors and their physicians...
  64. pmc Medicare drugs
    John A Poisal
    Health Care Financ Rev 25:1-5. 2003
    ....
  65. ncbi Financial consequences of drug benefit plans
    Bartholomew E Clark
    JAMA 289:423; author reply 424. 2003
  66. ncbi The new Medicare prescription-drug legislation
    Drew E Altman
    Henry J Kaiser Family Foundation, Menlo Park, Calif, USA
    N Engl J Med 350:9-10. 2004
  67. ncbi The effect of incentive-based formularies on prescription-drug utilization and spending
    Haiden A Huskamp
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    N Engl J Med 349:2224-32. 2003
    ..Many employers and health plans have adopted incentive-based formularies in an attempt to control prescription-drug costs...
  68. ncbi Advocating for a Medicare prescription drug benefit
    John Rother
    AARP, USA
    Yale J Health Policy Law Ethics 3:279-90. 2003
  69. ncbi Prescription drug access: the ANA adopts principles to evaluate congressional Medicare proposals
    Erin McKeon
    ANA s Department of Government Affairs
    Am J Nurs 103:106. 2003
  70. ncbi Will reference pricing address the health cost conundrum?
    John K Iglehart
    Health Aff (Millwood) 22:7-8. 2003
  71. ncbi Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk?
    Susan E Andrade
    Meyers Primary Care Institute Fallon Healthcare System, Worcester, Massachusetts 01605, USA
    J Am Geriatr Soc 50:178-81. 2002
    ..The vast majority of older people choosing less-comprehensive drug benefit plans appeared to make appropriate choices of plans based upon past utilization of prescription and other medical services...
  72. ncbi The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?
    Haiden A Huskamp
    Department of Health Care Policy, Harvard Medical School, USA
    Health Aff (Millwood) 22:149-58. 2003
    ..We find that the VHA National Formulary was effective at shifting prescribing behavior toward the selected drugs, achieving sizable price reductions from manufacturers, and greatly decreasing drug spending...
  73. ncbi Government commitment and regulation of prescription drugs
    Richard G Frank
    Department of Health Care Policy, Harvard Medical School, Boston, USA
    Health Aff (Millwood) 22:46-8. 2003
    ..I conclude that the federal government should exercise caution when attempting to regulate prescription drug prices...
  74. ncbi Reference pricing for drugs: is it compatible with U.S. health care?
    Panos Kanavos
    Harvard Medical School, USA
    Health Aff (Millwood) 22:16-30. 2003
    ..This paper explores the difficult trade-offs that policymakers must make in designing such a system, drawing where relevant from experience abroad...
  75. ncbi Drug card setback highlights need for cost relief
    Richard L Gundling
    Healthc Financ Manage 57:50-4. 2003
    ....
  76. pmc Impact of generosity level of outpatient prescription drug coverage on prescription drug events and expenditure among older persons
    Margaret B Artz
    Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
    Am J Public Health 92:1257-63. 2002
    ..This study examined the impact of drug coverage generosity on older persons' prescription events (fills) and expenditures...
  77. ncbi Impact of health plan design and management on retirees' prescription drug use and spending, 2001
    Cindy Parks Thomas
    Schneider Institute for Health Policy, Brandeis University, Waltham, Massachusetts, USA
    Health Aff (Millwood) . 2002
    ..Although we did not find lower rates of use in plans with aggressive cost sharing, this may be attributable in part to their higher drug use associated with mail-order incentives...
  78. ncbi Employer drug benefit plans and spending on prescription drugs
    Geoffrey F Joyce
    RAND Health, 1700 Main St, Santa Monica, CA 90407 2138, USA
    JAMA 288:1733-9. 2002
    ..It is unknown how these initiatives affect drug costs...
  79. ncbi Approaches to pharmacy benefit management and the impact of consumer cost sharing
    Bridget M Olson
    The University of Arizona, College of Pharmacy, Center for Health Outcomes and PharmacoEconomic Research, Tucson, Arizona 85721 0207, USA
    Clin Ther 25:250-72. 2003
    ..An understanding of the most prominent mechanisms of benefit management is an important step in determining the most effective approach to take in future years...
  80. ncbi Financial consequences of drug benefit plans
    Brenda Motheral
    JAMA 289:423-4; author reply 424. 2003
  81. ncbi Financial consequences of drug benefit plans
    John Hsu
    JAMA 289:423; author reply 424. 2003
  82. ncbi Controlling spending for prescription drugs
    Stuart H Altman
    N Engl J Med 346:855-6. 2002
  83. ncbi Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries
    Joy H Lewis
    RAND Health, Santa Monica, Calif 90407 2138, USA
    N Engl J Med 346:830-5. 2002
    ..Because Medicare beneficiaries may not be accustomed to presenting their Medicare cards at pharmacies, we assessed the compliance of pharmacies with Senate Bill 393...
  84. ncbi The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey
    Lesley H Curtis
    Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Med Care 42:439-46. 2004
    ..Despite continuing debate over a prescription drug benefit for the Medicare program, there has been relatively little research estimating the potential cost of providing such a benefit...
  85. ncbi The prescription-drug problem
    Robert Steinbrook
    N Engl J Med 346:790. 2002
  86. ncbi Affordable prescription drugs for NC consumers: the next challenge
    Helen H Savage
    AARP NC, Raleigh, NC, USA
    N C Med J 64:298-9. 2003
  87. ncbi Managing prescription drug costs
    J M Sica
    Aon Consulting, Conshohocken, Pennsylvania, USA
    Empl Benefits J 26:35-40. 2001
    ..The author also discusses pharmacy benefit managers, as well as various utilization management strategies like benefit plan design and the use of formularies...
  88. ncbi Employer-sponsored health insurance and prescription drug coverage for new retirees: dramatic declines in five years
    Bruce Stuart
    Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, USA
    Health Aff (Millwood) . 2003
    ..Losses among males, the group most affected, would have been even greater had it not been for a slight increase in benefits from spouses' policies...
  89. ncbi The Maine Rx prescription drug plan and the dormant Commerce Clause doctrine: the case of the missing link[age]
    Brannon P Denning
    Southern Illinois University School of Law, USA
    Am J Law Med 29:7-30. 2003
  90. ncbi Viagra: a success story for rationing?
    Rudolf Klein
    London School of Hygiene and the London School of Economics
    Health Aff (Millwood) 21:177-87. 2002
    ..The case of Viagra, it concludes, holds out two general lessons: first, allow exceptions to total bans on reimbursement; second, involve the medical profession in the decision-making process...
  91. ncbi Prevalence of opioid dispensings and concurrent gastrointestinal medications in an elderly population from Ontario, Canada
    Rachel Williams
    GlaxoSmithKline, Worldwide Epidemiology, Research Triangle Park, North Carolina, USA
    J Opioid Manag 4:193-200. 2008
    ....
  92. ncbi Targeting the middlemen. Pharmacy benefits managers under fire for prices
    Cinda Becker
    Mod Healthc 33:30. 2003
  93. ncbi Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage
    Deborah A Taira
    Hawaii Medical Service Association BBS of Hawaii, Honolulu, Hawaii 96808 0860, USA
    Am J Manag Care 9:305-12. 2003
    ....
  94. ncbi Physicians' views of formularies: implications for Medicare drug benefit design
    Bruce E Landon
    Harvard Medical School, Beth Israel Deaconess Medical Center, USA
    Health Aff (Millwood) 23:218-26. 2004
    ....
  95. ncbi Drugs and dentistry. Why do pharmacists call dentists?
    Michael Jackson
    Florida Pharmacy Association, USA
    Todays FDA 20:29, 31. 2008
  96. ncbi Does prior authorization of sibutramine improve medication compliance or weight loss?
    Joseph A Risser
    Lindora Medical Clinics, 3505 Cadillac Avenue, Suite N 2, Costa Mesa, CA 92626, USA
    Obes Res 13:86-92. 2005
    ..The underlying hypothesis is that physician advocacy through prior authorization increases patient compliance and treatment outcomes...
  97. ncbi Enterprising pharmacists use Medicare card to lower costs for health system, patients
    Donna Young
    Am J Health Syst Pharm 61:2462, 2465-6, 2472. 2004
  98. ncbi Drug coverage in Canada: who is at risk?
    Vishnu Kapur
    Health Canada, Microsimulation Modelling and Data Analysis Division, Jeanne Mance Building, 5th Floor, PL 1950C Tunney s Pasture, Ottawa, Ont, Canada K1A 0K9
    Health Policy 71:181-93. 2005
    ..The paper then goes on to analyze the level of such coverage in terms of out-of-pocket drug expenses faced by Canadian families in an effort to identify gaps in coverage...
  99. ncbi Dawn of a new health care delivery model
    Marialice S Bennett
    College of Pharmacy, Ohio State University, Columbus, USA
    J Am Pharm Assoc (2003) 44:420, 422. 2004
  100. ncbi Oh, Canada: comparing single-payer health care with practice in the United States
    James C Shaw
    Am J Med 118:1064-6. 2005
  101. ncbi Relationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy--results from a managed care administrative claims database
    Michael T Eaddy
    Applied Health Outcomes, 3488 East Lake Rd, Suite 201, Palm Harbor, FL 34685, USA
    J Manag Care Pharm 11:145-50. 2005
    ..The purpose of this study was to investigate the association between SSRI utilization patterns and the use of health care services in the managed care environment...

Research Grants59

  1. INAPPROPRIATE PRESCRIBING AND RISK FACTORS IN ELDERLY
    Gordon Liu; Fiscal Year: 2001
    ..Third, existing research has not satisfactorily distinguished how individual and organizational features contribute differently to the likelihood vs. The quantity of inappropriate predescribing in the elderly. ..
  2. Effects of Mental Parity on High-Cost and Severely-Ill Individuals
    Haiden A Huskamp; Fiscal Year: 2011
    ..We will estimate a combination of two-part random-effects models for longitudinal data, latent class random-effects models, logistic regression models, Poisson regression models, and hazard models to address these aims. ..
  3. Economics of Formulary Design and Mental Health Policy
    Haiden Huskamp; Fiscal Year: 2006
    ..Huskamp the training, mentoring, time and resources to develop the skills that will put her in a position to lead independent research on the economics of pharmaceutical treatment for mental illnesses. ..
  4. Medication Management Decisions in Schizophrenia
    Mark Olfson; Fiscal Year: 2003
    ..The results will inform quality improvement programs by identifying key modifiable determinants of the quality of medication management in the community treatment of schizophrenia. ..
  5. Effect of a Restrictive Formulary on Low Income Children
    JULIE URMIE; Fiscal Year: 2007
    ..Instrumental variable analysis will be used to examine the effect of changes in antidepressant prescribing patterns caused by the restrictive formulary on health care costs. [unreadable] [unreadable] [unreadable] [unreadable]..
  6. Impact of Medicaid Policy on cardiovascular drug use and clinical outcomes
    Michael A Fischer; Fiscal Year: 2010
    ....
  7. Life Cycle Effects of Health Insurance on Elderly Health
    Jalpa Doshi; Fiscal Year: 2006
    ..We will use these estimates to simulate the effect of changes in the age of Medicare eligibility on health, medical service use and Medicare expenditure. ..
  8. Impact of Medicaid Prescription Copayments in Patients with Schizophrenia
    Jalpa Doshi; Fiscal Year: 2009
    ..The findings of our study will help inform policymakers about the intended and unintended consequences of prescription copayments in Medicaid patients with schizophrenia. ..
  9. HRQL Impact of Chronic Conditions and Comorbidity Burden
    Patrick Sullivan; Fiscal Year: 2006
    ..S. [unreadable] [unreadable]..
  10. Economic Impacts of New Drugs
    Sharon Lise Normand; Fiscal Year: 2006
    ..Finally, we will examine the proposition that offsets occur differentially across racial and ethnic groups, for high utilizers and according to the organization of insurance arrangements. [unreadable] [unreadable]..
  11. CEA in CTN: Bup/Nal treatment for opioid addicted youth
    Daniel Polsky; Fiscal Year: 2006
    ..abstract_text> ..
  12. Comparative Effectiveness of Comprehensive Care for Adults with SMI
    TODD PATRICK GILMER; Fiscal Year: 2010
    ....
  13. Vulnerable Populations and Special Protections in ACTUs
    Sohini Sengupta; Fiscal Year: 2007
    ..abstract_text> ..
  14. Using MEPS Data to Inform Public-Plan Consumerism
    Matthew Davis; Fiscal Year: 2007
    ..Findings will have immediate relevance for implementation of the HOA projects and other consumerism efforts. [unreadable] [unreadable] [unreadable]..
  15. Access to Care: Children with Special Health Care Needs
    Alex Chen; Fiscal Year: 2008
    ..Phase II is the development of an access-to-care survey instrument and limited-scope primary data collection to further examines factors impacting access to care for CSHCN. [unreadable] [unreadable]..
  16. Research Center on Managed Care and Drug Abuse Treatment
    Constance Horgan; Fiscal Year: 2008
    ..This pilot will explore the feasibility for a large-scale study of the incremental impact of adding a substance abuse treatment parity benefit to private health insurance in California. ..
  17. Hurricane Katrina Community Advisory Group
    Ronald C Kessler; Fiscal Year: 2010
    ....
  18. Financial Incentives and Variations in the Care of Medicare Beneficiaries
    Bruce E Landon; Fiscal Year: 2010
    ..Because patients will be clustered within physicians and physicians clustered within markets, we will use hierarchical analytic methods. ..
  19. Market Competition and the Quality of Home Health Services
    DANIEL E POLSKY; Fiscal Year: 2010
    ....
  20. EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION
    Kenneth Warner; Fiscal Year: 2004
    ....
  21. DEPRESSIVE DISORDERS IN PRIMARY CARE AND WORK SETTINGS
    Benjamin Druss; Fiscal Year: 2003
    ..This project will compare the impact of depression and three chronic medical illnesses on health costs, absenteeism and job performance ratings both cross-sectionally and over time. ..
  22. Prescription Drug Coverage and Health Outcomes in Elders
    Jennifer Tjia; Fiscal Year: 2008
    ..abstract_text> ..
  23. Statistical Methods for Cost Research in Alcohol Studies
    Daniel Polsky; Fiscal Year: 2004
    ..By developing the methodology of cost analysis we aim to improve the policy relevance and interpretability of economic evidence in trial based data. ..
  24. A Comprehensive Database of Cost-Effectiveness Analyses
    Peter Neumann; Fiscal Year: 2003
    ..The web-based data should also understand the needs of different scientists to be understood and policymakers, and bridges to be built across disparate communities. ..
  25. Workplace Mental Health Benefits & Selective Contracting
    Anthony Losasso; Fiscal Year: 2002
    ..Our study will offer lessons from which other purchasers, including the federal government, may learn. ..
  26. RURAL RESPONSE TO MEDICARE+CHOICE: CHANGE AND ITS IMPACT
    Keith Mueller; Fiscal Year: 2001
    ..Results of this study will be shared annually with the policy community and others through the publication series of the Rural Policy Research Institute. ..
  27. Impact of Poor Health & AIDS on Small Businesses in SA
    Mark Pauly; Fiscal Year: 2003
    ..They will be useful for predicting the effect of changes in health on economic activity in this sector, and for allocating resources for disease prevention and treatment. ..
  28. Methadone Benefit Elimination--Oregon Health Plan
    Bret Fuller; Fiscal Year: 2003
    ..abstract_text> ..
  29. DRUG ABUSE TREATMENT UNDER MANAGED CARE--ROLE OF PPOS
    Constance Horgan; Fiscal Year: 2002
    ..This study will provide systematic information on the nature and extent of these changes. ..
  30. Systems integration and substance abuse service delivery
    Heather Larkin; Fiscal Year: 2004
    ..The ultimate impact of increased continuity within the system on the health of the population at large is likely to offer a significant cost-reduction to society. ..
  31. Adapting a Medical Self-Management Program for a Community Mental Health Center
    Benjamin Druss; Fiscal Year: 2008
    ..If successful, it will provide a sustainable, scalable model for improving medical self-management in a highly vulnerable population. ..
  32. External Costs of Obesity
    Jay Bhattacharya; Fiscal Year: 2008
    ..unreadable] [unreadable] [unreadable]..
  33. The Safety Net, Medicaid, and Child Health Outcomes
    Anthony Losasso; Fiscal Year: 2009
    ..A final area of study will examine how the relationship between the health care safety net and children's health outcomes differs by race and ethnicity. ..
  34. PRICE INDEXES OF MENTAL HEALTH TREATMENT
    Richard Frank; Fiscal Year: 2002
    ..To assess outcomes we will use clinical literature along with three expert panels of clinician-researchers to rate expected outcomes for specific combinations of consumers and treatments. ..
  35. Specialty Mental Health Care--Expanding Access in an HMO
    Dominic Hodgkin; Fiscal Year: 2003
    ..The results will inform health plan decision-makers and others as they make utilization management choices that may have a major impact on patients and enrollee populations overall. ..
  36. Challenging Life Events in Older Persons
    TIMOTHY DAALEMAN; Fiscal Year: 2005
    ..e. social support, mental health status. Secondary aims include learning how a baseline measure of patient spirituality predicts future death attitudes and discussions of advance care planning. ..
  37. The Role of Customization in Psychotropic Prescribing
    Dominic Hodgkin; Fiscal Year: 2009
    ....
  38. EMPLOYMENT DYNAMICS IN RESPONSE TO WELFARE REFORM
    Isaac Montoya; Fiscal Year: 2002
    ..Analyses will yield an Employment Readiness Profile that summarizes the changes over time within and between the samples of drug users and non-drug users and the independent effect of drug use on achieving employment. ..
  39. Peer Support--Congestive Heart Failure Self-Management
    MARY ELLEN HEISLER; Fiscal Year: 2009
    ..If found effective, this approach could be used to improve health outcomes among patients with other chronic conditions, such as depression, chronic pain, or diabetes. ..
  40. MENTAL DISORDERS AS RISK FACTORS FOR SUBSTANCE DISORDERS
    Ronald Kessler; Fiscal Year: 2003
    ....
  41. Risk Factors for Psychopathology in the WHO WMH Surveys
    Ronald Kessler; Fiscal Year: 2009
    ..Third, the level of detail in the description of data analysis plans has been substantially expanded in this revised submission in response to reviewer comments. ..
  42. Reimbursement Policy and Cancer Chemotherapy
    Joseph Newhouse; Fiscal Year: 2009
    ..Understanding its impact on chemotherapy treatment patterns has important implications not only for Medicare spending but also for the welfare of beneficiaries with cancer. ..
  43. Osteoporosis Prevention in Early Stage Breast Cancer
    Dawn Hershman; Fiscal Year: 2006
    ..abstract_text> ..
  44. Do Free Glucose Test Strips Increase Self-Monitoring?
    Andrew Karter; Fiscal Year: 2003
    ..Proposal strengths also include a longitudinal design, substantial statistical power, low cost data acquisition, and an ethnically diverse population with uniform access to care. ..
  45. Outreach and Treatment for Depression in the Labor Force
    Ronald Kessler; Fiscal Year: 2005
    ..This is an extremely important opportunity for rapid and widespread dissemination in an area of research where dissemination of positive results has traditionally been a serious problem. ..
  46. Epoetin Therapy and Survival of Hemodialysis Patients
    Dennis Cotter; Fiscal Year: 2006
    ..Our goal is to insure that treatment !patterns for this high-risk population are rationally based to provided the patients with the best possibilities for survival. ..
  47. Reducing benzodiazepines and hip fracture in the elderly
    Stephen Soumerai; Fiscal Year: 2004
    ..Phase II analyses will also contribute a novel method for evaluating health outcomes of changes in medication use in large populations. ..
  48. Quantifying the Value of Value-Based Purchasing
    Ronald Kessler; Fiscal Year: 2006
    ..abstract_text> ..
  49. MD Group Characteristics and Quality of Care for CHD
    Bruce Landon; Fiscal Year: 2003
    ..abstract_text> ..
  50. Ethnic Disparities in Diabetes Complications
    Andrew Karter; Fiscal Year: 2008
    ..abstract_text> ..
  51. The Effects of Formularies and Pharmaceutical Promotion on Physicians' Prescribin
    GREGORY KRUSE; Fiscal Year: 2008
    ..These models will be estimated for all patients and separately for new and switch prescriptions. [unreadable] [unreadable] [unreadable]..
  52. Immune Thrombocytopenia and Low-Level Mercury Exposure
    Jodi Segal; Fiscal Year: 2006
    ..Segal with the necessary support for successful completion [unreadable] [unreadable] [unreadable]..
  53. Impact of 3 Tier Drug Copays on Use and Spending
    Dominic Hodgkin; Fiscal Year: 2003
    ..abstract_text> ..
  54. Impact of Prior Approval for Antidepressants in Medicaid
    Stephen Soumerai; Fiscal Year: 2007
    ..All analyses will be stratified by type of disability (mental, physical, developmental). ..
  55. Cost-Related Underuse of Medications in the Elderly
    Stephen Soumerai; Fiscal Year: 2006
    ..unreadable] [unreadable]..
  56. Archiving the Charleston Heart Study
    Paul Nietert; Fiscal Year: 2002
    ..abstract_text> ..
  57. Educational Disparities in Diabetes Complications
    Andrew Karter; Fiscal Year: 2006
    ..abstract_text> ..